Baltimore Innovation Week 2017

Milt Reder is VP of Engineering at Yet Analytics, where he and his team use Clojure(Script) to model human experience, learning and performance. He is a co-organizer of the Baltimore Clojure meetup, now in its 4th year.

Gary is a Data Engineer at Arena.io. He dabbles in UI and knows way too much Clojure. He has applied FP languages (currently OCaml) and approaches to problems for over 6 years in Baltimore.

Tom Kraak is a JavaScript developer at Oath, a subsidiary of Verizon, which houses 50+ media and technology brands including AOL, Yahoo, and HuffPost. He is passionate about learning, teaching, and the web platform. Tom combines these passions in frequent contributions to his favorite open source projects on GitHub. Besides the long-standing Academy course at Betamore, he teaches and mentors at Thinkful, Baltimore NodeSchool and various local meetups for junior web developers.

Emily P. English is the Chief Product Officer and Interim President of Gemstone Biotherapeutics, LLC. In this role, she will lead Gemstone’s product development plans to bring innovative wound healing technologies from the lab bench into the clinic. She thrives on for working with small teams at the leading edge of technology development, and she brings a passion shaped by personal experience to the development of wound healing solutions. Prior to joining Gemstone, Dr. English spent eight years at the Johns Hopkins University Applied Physics Laboratory, where she was the Global Communications Program Manager. She holds a Bachelor’s degree, Magna cum laude, in chemistry from the University of Maryland, College Park, and a Ph.D. in chemistry from the University of Wisconsin, Madison. Outside of work, Dr. English enjoys spending time with her family, and she is an avid curler.

Stephen Auvil is the senior vice president for technology transfer and commercialization at the Maryland Technology Development Corporation (TEDCO). In this role, he is responsible for overseeing TEDCO’s funding programs. He is also responsible for other programs that foster the transfer of technologies from universities and federal laboratories into the commercial sector. From 2008 - 2010, Mr. Auvil served as the assistant vice president for research at the University of Maryland, Baltimore County (UMBC) where he assisted UMBC’s vice president for research in his effort to build and support UMBC’s research enterprise. He was also responsible for supporting UMBC’s economic development mission as it relates to research, technology transfer, and new venture creation. Mr. Auvil, who was one of the architects of UMBC’s ACTiVATE® and INNoVATE™ programs, served as a co-principal investigator on the National Science Foundation grants that supported these programs. From 2000 - 2008, Mr. Auvil served as the director of UMBC's Office of Technology Development (OTD). During his tenure, he oversaw significant growth in OTD’s active license agreements, intellectual property portfolio, and licensing revenues. He actively promoted UMBC’s research capabilities and helped to build ties with Maryland companies. Before arriving at UMBC, he worked as an assistant director in the Office of Technology Licensing at the Johns Hopkins University School of Medicine where he evaluated inventions and negotiated license agreements for a variety of technologies. He has successfully negotiated dozens of license agreements including many agreements involving equity and faculty initiated start-up companies. Prior to working at Johns Hopkins, Mr. Auvil worked for two small medical device companies where he had a variety of responsibilities ranging from rebuilding medical devices under GMP to setting-up and networking computerized accounting systems. He began his career as a laboratory technician studying ion channels in membranes. Mr. Auvil graduated with a Bachelor of Science degree in Biology and Engineering Science from Loyola College in Maryland, and went on to earn a Masters of Business Administration from the University of Baltimore and a Masters of Science in Biotechnology from the Johns Hopkins University.

Julia Spicer serves as the Executive Director for the Mid-Atlantic Venture Association (MAVA) and fosters innovation and company building by bringing together private and public investment capital and high growth enterprises across stage and industry. As head of MAVA, Ms. Spicer presents industry thought-leaders and best practices in support of emerging as well as established companies. From helping the earliest of innovators secure seed capital to discussing the latest in market intelligence important to high growth enterprises, she supports the full life cycle of company growth and investment interests. Her corporate technology career, experience in private investment, and most notably, her early entrepreneurial roots as company founder provide a useful foundation for fostering the success of high growth technology companies, from start-up to exit. She joined MAVA from Columbia Capital, a private equity growth capital firm specializing in communications technology. Previously, she served as Corporate Vice President of Strategic Planning and Communications for GTE Corporation, with responsibilities for investor relations and both public policy and strategic positioning for the company’s $4B emerging technology businesses which included wireless, mobile, air-to-ground, satellite, and R&D operations. Ms. Spicer also served as President of the GTE Foundation, one of the top 20 corporate foundations in the United States, focusing principally on science and mathematics education and the arts. An industry leader, Spicer founded TechBUZZ which to date over a five year period has helped launch more than 330 early market-entry companies, which have collectively raised more than $700M in reported seed and follow-on investments. In 2008, she was instrumental in launching a first-ever Mid-Atlantic Bio initiative to further support the biotechnology industry and encourage collaboration among investors, industry, academia and companies from laboratory to exit. Spicer has served or is currently on the boards of the Network of Teaching Entrepreneurship (NFTE), an international organization assisting disadvantaged children through chapters located in 33 countries; the University of Maryland’s Clark School of Engineering Board of Visitors; Summit Executive Resources; and Able Flight, a scholarship program providing assistance to individuals with disabilities by challenging them through flight training. Through a gubernatorial appointment, Ms. Spicer serves on the Commonwealth Health Research Board, which has the primary responsibility to make grants for human health research, especially for those efforts that have the potential of maximizing human health benefits for citizens of the Commonwealth. Ms. Spicer is a graduate of the University of North Carolina, where she was a Morehead-Cain Scholar.

Robert Lord is the Co-Founder and President of Protenus, an analytics platform that leverages artificial intelligence to detect data breaches in healthcare. Protenus protects the nation’s top healthcare systems, ensuring trust for tens of millions of patients, and was named the 2016 International Association of Privacy Professionals’ Privacy Innovator of the Year.

Robert is a sought-after speaker and commentator in the fields of artificial intelligence, cybersecurity, healthcare analytics, and data privacy. He has been invited to speak at premier industry conferences like the HIMSS17 National Conference, to brief at the U.S. Senate, and to provide insight to national, state, and local leaders on cybersecurity preparedness. His insights have been featured in The Wall Street Journal, The Hill, Forbes, The Baltimore Sun, and a wide array of other publications.

Robert is a Fellow at the Institute for Critical Infrastructure Technology and teaches courses on entrepreneurship at Johns Hopkins. He has been named to the Baltimore Business Journal’s “Tech 10” and to Becker’s Hospital Review’s “Healthcare Entrepreneurs to Know.”

Before co-founding Protenus, Robert was an MD candidate at the Johns Hopkins University School of Medicine. Robert received his A.B. in Social Studies, magna cum laude, from Harvard University.

David W. Wise is the Director the Maryland Momentum Fund a new initiative of the University System of Maryland (USM) to provide late seed investment funding for promising technology ventures that come out of any of the twelve constituent institutions of the University System or its incubators. Mr. Wise has a business career spanning over thirty years including serving eight and half years as CEO of The Genetics & IVF Institute in Fairfax, Virginia an international women's healthcare company with operations in both the US and China of which the Inova Health System was the largest shareholder. In 2014 he decided to shift the focus of his career to helping develop the innovation economy in Maryland. Since 2014 he has been the Venture Advisor to the President of the Abell Foundation on its direct investment program. He is also an advisor to UM Ventures and the Sinai/LifeBridge Health Bioincubator. In addition, he is a member of the Betamore Advisory Board and of the Board of the Maryland Humanities Council and sits on the Bioscience Committee of the Greater Baltimore Committee. He has served as a business competition judge for Accelerate Baltimore, Beta City, and at both the Fischell School in College Park and their School of Medicine of the University of Maryland, among others.

In his position with the Momentum Fund Mr. Wise will be responsible for the review and due diligence and recommendations on investments by the Momentum Fund. In addition, he in conjunction with members of the UM Ventures team, will work with these early stage companies to provide business advice and counseling to help promote their success. Mr. Wise graduated with highest honors from the University of Dayton and received a graduate degree in international business from The Fletcher School of Law and Diplomacy at Tufts University.